T-041

托吡酯-D₁₂ 溶液

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

• 经验公式（希尔记法）: C₁₂D₁₂H₉NO₈S
• CAS号: 1279037-95-4
• 分子量: 351.44
• EC號碼: 200-659-6
• MDL號碼: MFCD09752150
• 分類程式碼代碼: 41116107
• PubChem物質ID: 329826605
• NACRES: NA.24

属性

• 等級: certified reference material
• 品質等級: 300
• 形狀: liquid
• 特點: Snap-N-Spike^®/Snap-N-Shoot^®
• 包裝: ampule of 1 mL
• 製造商／商標名: Cerilliant^®
• 濃度: 100 μg/mL in methanol
• 技術: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• 應用: clinical testing
• 形式: single component solution
• 儲存溫度: −20°C
• SMILES 字串: [2H]C([2H])([2H])C1(O[C@H]2CO[C@@]3(COS(N)(=O)=O)OC(O[C@H]3[C@H]2O1)(C([2H])([2H])[2H])C([2H])([2H])[2H])C([2H])([2H])[2H]
• InChI: 1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7?,8?,9-,12-/m0/s1/i1D3,2D3,3D3,4D3
• InChI 密鑰: KJADKKWYZYXHBB-FTZSVORRSA-N

说明

一般說明

该认证溶液标准品可适合用于包括作为内标用于尿液等生物基质中托吡酯水平的定量，或用于通过LC/MS或GC/MS的同位素稀释法进行临床毒理学、尿液药物测试或法医分析应用。以商品名Topamax^®进行销售的托吡酯，是一种用于治疗癫痫发作的抗癫痫药物。 托吡酯与兴奋剂苯丁胺的组合可构成新型减肥药Qsymia中的活性化合物^®。

應用

• Quantitative determination of topiramate in human plasma: A method employing liquid chromatography tandem mass spectrometry was developed to quantitatively determine topiramate in human plasma, highlighting the precision and applicability of using advanced analytical techniques for therapeutic drug monitoring in clinical settings (Popov et al., 2013).


• Dried blood spots technique for topiramate: The development and validation of a dried blood spots technique for quantitative determination of topiramate using liquid chromatography-tandem mass spectrometry was conducted. This method offers a minimally invasive sample collection option that could improve therapeutic drug monitoring for patients on topiramate (Popov et al., 2013).


• Therapeutic drug monitoring by LC-MS/MS: A study described a robust method for the therapeutic drug monitoring of topiramate using liquid chromatography-tandem mass spectrometry (LC-MS/MS), providing essential data on drug stability and concentration levels necessary for effective patient management (Matar, 2010).

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Qsymia is a registered trademark of Vivus, Inc.

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Topamax is a registered trademark of Johnson & Johnson

安全信息

• 象形圖: GHS02,GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H225,H301 + H311 + H331,H370
• 防範說明: P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311
• 危險分類: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• 標靶器官: Eyes
• 儲存類別代碼: 3 - Flammable liquids
• 水污染物質分類（WGK）: WGK 1
• 閃點（°F）: 49.5 °F - closed cup
• 閃點（°C）: 9.7 °C - closed cup